Back to Search
CHITRA HOSING, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1245322262IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
K8216(TX)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
OTHER
Class of 1990
Research & Publications (20)
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
PMID 19384931·Am J Hematol·2009
8-other
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
PMID 18272911·Ann Oncol·2008
8-other
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
PMID 16681642·Br J Haematol·2006
3-trial
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
PMID 16923559·Leuk Lymphoma·2006
8-other
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
PMID 15937511·Bone Marrow Transplant·2005
8-other
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
PMID 12702528·Ann Oncol·2003
4-observational
The choice of allogeneic or autologous hematopoietic transplantation for NHL.
PMID 12194722·Cytotherapy·2002
8-other
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
PMID 11996478·Ann Oncol·2002
8-other
Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
PMID 11319299·Am J Clin Oncol·2001
5-case
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
PMID 19363221·Blood·2009
3-trial
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
PMID 19539212·Biol Blood Marrow Transplant·2009
3-trial
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
PMID 19654407·Blood·2009
8-other
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.
PMID 19237479·Ann Oncol·2009
8-other
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
PMID 19144658·Haematologica·2009
8-other
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
PMID 19660722·Biol Blood Marrow Transplant·2009
8-other
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
PMID 19168784·Blood·2009
8-other
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
PMID 18411419·Blood·2008
3-trial
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
PMID 18564354·Br J Haematol·2008
8-other
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
PMID 19041063·Biol Blood Marrow Transplant·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1245322262
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile